Remark (MARK) Stock Price, News & Analysis

Company Overview

Remark Holdings, Inc. provides AI-powered analytics, computer vision, and smart agent solutions. The company operates a data and AI software platform that offers AI-based computer vision products, computing devices, and software-as-a-service solutions; and Smart Safety Platform, a software solution that uses computer vision to detect persons, objects, and behavior in video feeds, as well as provides Remark AI Thermal kits and rPads products and services. It serves retail, construction, public safety, workplace safety, and public sectors. The company was formerly known as Remark Media, Inc. and changed its name to Remark Holdings, Inc. in April 2017. Remark Holdings, Inc. is headquartered in Las Vegas, Nevada.

Key Stats

• Today's Range: $0.10 to $0.10
• 50-Day Range: $0.09 to $0.12
• 52-Week Range: $0.08 to $1.49
• Volume: 119,766 shs
• Average Volume: 3.41 million shs
• Market Capitalization: $4.91 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MARK Stock Analysis - Frequently Asked Questions

How have MARK shares performed this year?

Remark's stock was trading at $0.4952 at the start of the year. Since then, MARK shares have decreased by 80.1% and is now trading at $0.0986.
View the best growth stocks for 2024 here.

How were Remark's earnings last quarter?

Remark Holdings, Inc. (NASDAQ:MARK) posted its quarterly earnings results on Monday, August, 19th. The information services provider reported ($0.12) EPS for the quarter. The information services provider had revenue of $3.70 million for the quarter.

How do I buy shares of Remark?

Shares of MARK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Remark own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Remark investors own include Sorrento Therapeutics (SRNE), ADMA Biologics (ADMA), Heat Biologics (HTBX), Organigram (OGI), Genius Brands International (GNUS), Matinas BioPharma (MTNB) and Vaxart (VXRT).

Company Calendar

• Last Earnings: 8/19/2024
• Today: 9/20/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: Communication services, not elsewhere classified
• Sub-Industry: Communication
• Current Symbol: NASDAQ:MARK
• CUSIP: N/A
• CIK: 1368365
• Web: www.remarkholdings.com
• Phone: (702) 701-9514
• Fax: 302-655-5049
• Employees: 70
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.57)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-29,150,000.00
• Net Margins: -759.98%
• Pretax Margin: -759.98%
• Return on Equity: N/A
• Return on Assets: -296.56%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.10
• Quick Ratio: 0.09

Sales & Book Value

• Annual Sales: $5.81 million
• Price / Sales: 0.85
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.89) per share
• Price / Book: -0.05

Miscellaneous

• Outstanding Shares: 49,872,000
• Free Float: 46,979,000
• Market Cap: $4.91 million
• Optionable: No Data
• Beta: 2.72